In a report released on January 14, Evan Seigerman from BMO Capital reiterated a Hold rating on Replimune Group, with a price target of $11.00. The company’s shares closed yesterday at $7.71.

Found this to be true across different models: The agent starts a python REPL to inspect some object. For any subsequent commands they automatically enter the REPL and try to execute terminal commands ...

Python is one of the most popular programming languages in the world today, with millions of developers using it for web development, data science, machine learning, automation, and more. If you’ve ...

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage. Shares fell sharply ...

On June 11, 2025, the Python core team released Python 3.13.5, the fifth maintenance update to the 3.13 line. This release is not about flashy new language features, instead, it addresses some ...

In this tutorial, we will discover how to harness the power of an advanced AI Agent, augmented with both Python execution and result-validation capabilities, to tackle complex computational tasks. By ...

The OpenAPI specification, and the Swagger suite of tools built around it, make it incredibly easy for Python developers to create, document and manually test the RESTful APIs they create. Regardless ...

Python 3.11 introduced the Specializing Adaptive Interpreter. When the interpreter detects that some operations predictably involve the same types, those operations are “specialized.” The generic ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. And no, in case you were wondering, python is not a snake in ...